About Alke Research Private Limited
Data last updated:
Alke Research Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 07 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U73100KA2020PTC141945. Its GSTIN is 29AAUCA4845L1ZU (Karnataka).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Thomaskutty Jalumparambil and Josekutty Alumparambil Joseph.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Site No 9 Maples Flat No. S – 001 Ground Floor 2nd Right Banahalli Bommasandra, Bangalore, Karnataka, India – 560099.
For more details, the company can be reached via its website alkeresearch.com.
Company details
Contact details
Alke Research Private Limited's registered office is in Bangalore, Karnataka.
- Registered AddressSite No 9 Maples Flat No. S – 001 Ground Floor 2nd Right Banahalli Bommasandra, Bangalore, Karnataka, India – 560099
- IndustryPharma, Pharma Contract R&D
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Alke Research Private Limited
FY 2023 filings availableFinancial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | |||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | |||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | |||
| Net Profit Margin | |||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Alke Research Private Limited, buy the company report.
Board of directors of Alke Research Private Limited
Alke Research has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Josekutty Alumparambil Joseph | Additional Director | 31 May 2024 | 2 Years 4 Months | Current |
| Thomaskutty Jalumparambil Also directs: Rotobash Apps Private Limited | Director | 01 Mar 2021 | 5 Years 7 Months | Current |
Legal cases
No court or tribunal cases involving Alke Research Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Alke Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Alke Research has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AAUCA4845L1ZU | Karnataka | Active | 08 Feb 2021 |
To see the full GST registrations and return filing status of Alke Research Private Limited, buy the company report.
Recent activity
Alke Research Private Limited has 8 board changes on record since 2021: 2 appointments and 6 cessations. The latest: Josekutty Alumparambil Joseph was appointed as Additional Director on 31 May 2024.
Frequently asked questions
Alke Research is an active private limited company based in Bangalore, Karnataka, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 07 December 2020 (6+ years old) and is registered under CIN U73100KA2020PTC141945.
Alke Research has 2 current directors:
- Josekutty Alumparambil Joseph - Additional Director
- Thomaskutty Jalumparambil - Director
The latest financial statements of Alke Research on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Alke Research is 29AAUCA4845L1ZU, registered in Karnataka.
The CIN (Corporate Identification Number) of Alke Research is U73100KA2020PTC141945. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Alke Research was incorporated on 07 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Bangalore.
Josekutty Alumparambil Joseph was appointed as Additional Director on 31 May 2024. Pavi Anand ceased to be Additional Director on 31 May 2024. Arunkumar Namachivayam ceased to be Director on 04 Feb 2022. Alke Research has 8 board changes on record in total.
Alke Research can be reached through the website alkeresearch.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Alke Research is at Site No 9 Maples Flat No. S – 001 Ground Floor 2nd Right Banahalli Bommasandra, Bangalore, Karnataka, India – 560099.
Alke Research operates in the pharma industry, in the pharma contract r and d segment.